A cluster of attention-grabbing announcements from ASX-listed biotech juniors this morning touched on several key pressure points for the sector — clinical timelines, regulatory clearance, scientific ...
Propelled by encouraging regulatory reforms since 2014, India is fast emerging as a much sought-after destination for global clinical trials. Streamlined approval timelines, clearer ethical guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results